Alnylam Pharmaceuticals, Inc. ALNY, announced today that it has filed a patent infringement lawsuit
against Tekmira Pharmaceuticals Corporation in the U.S. District Court of the
District of Massachusetts. Alnylam's infringement suit against Tekmira is
based upon Tekmira's research activities providing lipid nanoparticle
(LNP)-formulated small interfering RNA molecules to a pharmaceutical
collaborator.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in